Advertisement

U.S. markets open in 6 hours 44 minutes

S&P Futures
4,634.50
-20.25(-0.44%)
Dow Futures
35,747.00
-49.00(-0.14%)
Nasdaq Futures
15,451.75
-144.00(-0.92%)
Russell 2000 Futures
2,150.90
-6.80(-0.32%)
Crude Oil
85.52
+1.70(+2.03%)
Gold
1,815.10
-1.40(-0.08%)

Advertisement

Pacific Biosciences of California, Inc. (PACB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

12.43

-0.77

(-5.83%)

At close: 04:00PM EST

12.48

+0.05

(+0.40%)

After hours:

07:41PM EST

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

Gap Down

View all chart patterns

Performance Outlook

Previous Close	13.20
Open	12.90
Bid	0.00 x 1800
Ask	0.00 x 1800
Day's Range	12.04 - 13.17
52 Week Range	12.04 - 53.69
Volume	7,535,145
Avg. Volume	2,793,848

Market Cap	2.742B
Beta (5Y Monthly)	1.12
PE Ratio (TTM)	N/A
EPS (TTM)	-0.19
Earnings Date	Feb 08, 2022 - Feb 14, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	40.33

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for PACB

Learn more

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Pacific Biosciences of Californ
Daily – Vickers Top Buyers & Sellers for 02/19/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Rating
Fair Value
Economic Moat
11 months agoArgus Research

All

News

Press Releases

Research Reports

Zacks
PacBio (PACB) Reports Impressive Preliminary Q4, FY21 Revenues
PacBio's (PACB) solid fourth-quarter results are likely to have been boosted by strong segmental performances and robust placement of Sequel systems.
GlobeNewswire
PacBio Grants Equity Incentive Award to New Employee
MENLO PARK, Calif., Jan. 14, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of PacBio common stock, and restricted stock units (“RSUs”) covering 40,000 shares of PacBio common stock, to a recently hired employee under the Pacific Biosciences 2020 Inducement Equity I
- Omineca Grants Stock Options
  CNW Group
- Meryllion Resources Corp. Announces Shares-for-Debt Transaction
  Newsfile
GlobeNewswire
PacBio Names Lara Toerien as Vice President and General Manager for the Americas
Industry Veteran Will Lead Company’s Commercial Growth Strategy in Americas RegionMENLO PARK, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate, sequencing platforms, welcomes Lara Toerien, Ph.D., as Vice President and General Manager for the company’s Americas region. Lara will be responsible for leading and developing PacBio’s commercial organization within North and South America while furthering its growth and market presenc